Welcome to LookChem.com Sign In|Join Free
  • or
(+)-Pentazocine is a synthetic opioid analgesic drug that belongs to the DEA Schedule IV classification, indicating it has a lower potential for abuse and addiction compared to Schedule I, II, and III substances. It was initially developed as an alternative to morphine, with the intention of providing effective pain relief while minimizing the risk of addiction. However, it has been found to have a high potential for abuse and dependence, leading to its classification as a Schedule IV drug. Pentazocine is used medically for moderate to severe pain management, but its use is strictly regulated due to its potential for misuse and the risk of adverse side effects, such as hallucinations, dizziness, and respiratory depression.

7361-76-4

7361-76-4 Suppliers

This product is a nationally controlled contraband or patented product, and the Lookchem platform doesn't provide relevant sales information.

7361-76-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 7361-76-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,3,6 and 1 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 7361-76:
(6*7)+(5*3)+(4*6)+(3*1)+(2*7)+(1*6)=104
104 % 10 = 4
So 7361-76-4 is a valid CAS Registry Number.

7361-76-4Relevant academic research and scientific papers

Pentazocine prodrug as well as preparation method and application thereof

-

, (2020/07/15)

The invention discloses a pentazocine prodrug shown as a formula (I), a preparation method thereof and medical application of a pharmaceutical preparation containing the pentazocine prodrug, wherein Ris hydrogen or deuterium. The water solubility of the prodrug compound is improved by 20 times or above at room temperature, the prodrug compound is chemically stable, the onset time is delayed, thedrug effect is prolonged, meanwhile, the same parent drug blood concentration is generated at a low dosage, and the prodrug compound has a wide clinical application prospect.

Asymmetric syntheses of (-)-pentazocine and (-)-eptazocine through an aza-prins cyclization

Chen, Qiang,Huo, Xing,Yang, Zhen,She, Xuegong

, p. 2543 - 2546,4 (2020/09/02)

Two down more to go: The asymmetric syntheses of (-)-pentazocine and (-)-eptazocine are presented. The highlights of the syntheses are the construction of the core skeleton through an aza-Prins cyclization and intramolecular Friedel-Crafts reaction. Copyr

Enantiocontrolled synthesis of (-)-9-epi-pentazocine and (-)-aphanorphine

Yang, Xiaobao,Zhai, Hongbin,Li, Zhong

supporting information; experimental part, p. 2457 - 2460 (2009/05/26)

(Chemical Equation Presented) We have developed novel asymmetric routes to (-)-9-epi-pentazocine and (-)-aphanorphine from a D-tyrosine derivative. The tricyclic frameworks of (-)-9-epi-pentazocine and (-)-aphanorphine were assembled stereoselectively via intramolecular Friedel-Crafts reaction of the corresponding bicyclic precursors, generated with titanium-promoted enyne cyclization and indium-initiated atom-transfer radical cyclization, respectively.

Combination of selected opioids with muscarine antagonists for treating urinary incontinence

-

, (2008/06/13)

Active compound combinations of compounds of group A, particularly opioids, and compounds of group B, particularly anti-muscarine agents and other substances suitable for treatment of an increased urge to urinate or urinary incontinence. Related pharmaceutical formulations and methods of treatment of an increased urge to urinate or urinary incontinence are also provided.

Migratory hydroamination: A facile enantioselective synthesis of benzomorphans

Trost, Barry M.,Tang, Weiping

, p. 8744 - 8745 (2007/10/03)

We describe a highly efficient, general strategy for the enantioselective synthesis of benzomorphans (45-46% overall yield from commercially available material). The new synthesis demonstrates the effectiveness of an unprecedented diastereoselective cycloisomerization via migratory hydroamination and the power of palladium-catalyzed asymmetric allylic alkylation (AAA) of simple ketone enolates in the context of complex synthesis. The strategy outlined here for the enantioselective synthesis of three contiguous stereogenic centers and the novel cycloisomerization should have many applications in alkaloid synthesis. Copyright

Analgesic 3-(3-methyl-3-butenyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-8-hydroxy-2,6-methano-3-benzazocine

-

, (2008/06/13)

Disclosed is 3-(3-methyl-3-butenyl)-1, 2, 3, 4, 5, 6-hexahydro-6, 11-dimethyl-8-hydroxy-2, 6-methano-3-benzazocine, a new derivative of benzazocine, which has superior analgesic properties.